Current trials
Recruiting
Phase iii
TUDCA-ALS (TUDCA)
Industry sponsored trial
TUDCA (tauroursodeoxycholic acid) is a small molecule that is being explored for its potential as a treatment for ALS
Read moreIn preparation
Phase iii
PreLude (Lithium carbonate)
Platform trial arm
Within an innovative platform design study, we will evaluate the efficacy of lithium carbonate in UNC13a homozygous patients.
Read moreIn preparation
Phase ii
Lighthouse (Triumeq)
Platform trial arm
Within an innovative platform design study, we will evaluate the efficacy of Triumeq, a therapy developed for treatment of HIV that has shown to slow progression in ALS
Read moreIn preparation
Phase iii
iAdore (Oral edaravone)
Platform trial arm
Within an innovative platform design study, we will evaluate the efficacy of oral edaravone (TW001), a formulation that reduces oxidative stress
Read more